Red blood cell-derived extracellular vesicles enable cisplatin and cetuximab combined therapy against triple-negative breast cancer.

Authors: Romano M, Musicò A, Tassoni S, Paolini L, Zendrini A, Gilberti E, Orlandi F, Pedrazzi T, Alacqua S, Segala A, Zenatelli R, Cifola I, Mangano E, Consolandi C, Camboni T, Signati L, Mazzucchelli S, Neva A, Ragni M, Severgnini M, Valerio A, Pomarico G, Almici C, De Palma G, Corsi F, Bergese P, Radeghieri A

Journal: Journal of nanobiotechnology